Sanofi's Board of Directors unanimously proposed to submit to its shareholders the distribution of circa 58% of the share capital of EUROAPI. Sanofi . In the first quarter, the Specialty Care division grew at a pace of more than 7% YoY, while Vaccines fractionally grew by 0.7%. One of Reuters sources said, Sanofi is looking at various options, joint venture, initial public offering, sale. For July 2022 GlaxoSmithKline [GSK.L] set the scene for one of the biggest listings in . "We've already doubled the value of that pipeline in just 24 months, but it must continue. The company operates in three major business segments, Pharmaceuticals, Vaccines and Consumer Healthcare. Get Your 7-Day Free Trial! Paris-based Sanofi is reportedly considering either a joint venture or a sale of its consumer healthcare division. Self-care can enhance wellbeing, prevent disease, curb illness, and restore health. Arguably the most well-known J&J product is its Covid-19 vaccine offering; the companys one-shot jab is the only single-dose coronavirus vaccine on the market, and is sold on a not-for-profit basis. Building on this foundation, Sanofi delivered a resilient underlying performance in the third quarter with strong sales in Specialty Care, largely driven by the continued outstanding performance of Dupixent. Real-time Euronext Paris Patents; Patient Support Services; Resources for Healthcare Providers; Colorado Disclosure; Vermont Disclosure; Our Responsibility. Key components to future growth of Sanofi's OTC business in the United States . The consensus recommendation is Strong Buy, based on a survey of 18 . Deal Overview. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. You may opt-out by. About Sanofi The company has also claimed that some of its major shareholders support the spin-off deal. In 2017, Sanofi completed a swap announced in June 2016, with Germanys Boehringer Ingelheim. Neither Sanofi nor EUROAPI assumes any responsibility for any violation of any such restrictions by any person. The earnings report showed what GSK called "strong sales" in its biopharma and consumer healthcare operations, to the tune of 7.1 billion British pounds (about $8.9 billion) and 2.6 billion . As part of Sanofi's ongoing efforts to reduce the complexity of its Consumer Healthcare portfolio and accelerate its growth trajectory, the company has signed an agreement with STADA for the divestiture of 16 Consumer Healthcare products commercialized in Europe. Therefore, their poor performance affects the overall results: General Medicines declined by 9% and Consumer Healthcare by 14% YoY. All rights reserved. It is provided for information only. The new head of the division, Julie Van Ongevalle, shared that the company will focus on core brands and categories while pursuing first-in-class Rx-to-OTC switches in the ED and flu categories in the U nited States. Sandrine Guendoul|+ 33 6 25 09 14 25 |sandrine.guendoul@sanofi.com Brentford, U.K.-based GSK, meanwhile, will spin out its consumer unit by mid-year, after turning down three bids from consumer goods giant Unilever PLC reaching 50 billion, which the drugmaker considered to undervalue the business. Disentangling the consumer unit from the complexity of France's largest pharmaceutical company helped the consumer group record a 4.6% year-on-year rise in 2021 sales, CEO Paul Hudson said. Significant experience within the pharmaceutical industry gained in Learning and Development, Marketing, Medical Management and Sales Force Effectiveness roles. Investigator Sponsored Studies and Externally Sponsored Collaboration, Access to Quality Healthcare Sanofi Global Health, Contributing to the eradication, elimination and control of some infectious diseases, Serving the needs of patients with non-communicable diseases, Development opportunity: how Sanofi empowers you, Press Release: Sanofi moves forward with EUROAPI listing on Euronext Paris, Sanofi will give its shareholders the opportunity to be part of EUROAPIs new chapter of growth through an additional extraordinary dividend in kind, EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions, The French State, through the fund French Tech Souverainet, intends to acquire 12% of EUROAPIs capital for up to 150 million from Sanofi to become a long-term reference shareholder of EUROAPI, As planned, Sanofi will continue to hold circa 30% of EUROAPI, post transaction, The overall transaction is subject to approval at the Sanofi 2022 Shareholders Meeting, and the AMF approval on EUROAPIs French prospectus. Global markets live: GM, Pfizer, Exxon, UBS, Boeing EUROAPI Announces Resignation of Corinne Le Goff as an Independent Member on the Board .. 12% in EUROAPI shares from Sanofi for up to 150 million, with the acquisition price to be determined based upon the thirty day volume weighted average trading price (VWAP) of EUROAPIs shares on Euronext Paris, starting on the first day of trading. In financial year 2020, STADA achieved group sales of EUR 3,010.3 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 713.3 million. As part of Sanofis ongoing efforts to reduce the complexity of its Consumer Healthcare portfolio and accelerate its growth trajectory, the company has signed an agreement with STADA for the divestiture of 16 Consumer Healthcare products commercialized in Europe. In addition to the previously proposed 3.33 cash dividend per Sanofi share, this additional extraordinary dividend, exclusively in kind, is subject to shareholders approval at Sanofi's May 3, 2022 Ordinary and Extraordinary Shareholders' Meeting. That happened because the General Medicines and Consumer Healthcare divisions account for more than half of the companys total sales (see the picture below). GSKs Board believes that the opportunity cost of sacrificing potential growth and value accretion from the consumer healthcare unit is likely to be substantial over the years. On June 23, 2021, GlaxoSmithKline plc (NYSE: GSK, $40.45, Market Cap: $101.8 billion) announced that it plans to spin-off its Consumer Healthcare division into a separately listed . In addition to its highly diversified customer base of approximately 530 customers, EUROAPI benefits from a strong and long-term customer relationship with Sanofi, which represented nearly half of EUROAPIs revenues in 2021. Further details regarding the specifics of the distribution, including the parity, and the timetable of the spin-off will be set forth in EUROAPIs French prospectus. The company, which is facing some notable patent expirations in the coming few years, has announced a plan to spin off its consumer healthcare business in 2023. With a diversified technology portfolio, EUROAPI is positioned as the world's leading manufacturer of small molecule API (including complex chemical synthesis molecules, biochemical molecules from fermentation and highly potent molecules). I am not receiving compensation for it (other than from Seeking Alpha). Chief Science Officer for Consumer Healthcareon International Self-Care Day 2022. Sanofi is offering its animal health unit Merial in exchange for Boehringer's consumer health, or non-prescription drugs, business plus 4.7 billion euros ($5.2 billion) in cash in exclusive . On the other hand, the remaining part is progressing nicely. Please disable your ad-blocker and refresh. Julie Van Ongevalle esgSubNav, Discover more about S&P Globals offerings. The French pharma giant first announced its intentions to spin off the API business in February.The plan, as the company said at the time, would combine Sanofi's API . We understand allergy sufferers needs and have a number of innovative, effective products in our range to respond effectively to each persons specific allergy needs. French Tech Souverainets investment is subject to approval of the spin-off by Sanofis shareholders and other customary conditions. And Scottish universities have a track record of securing UK funding. Partnered with business leaders to facilitate the Retired after 24+ year career with J&J. The companys operations are currently divided in four parts: The first two divisions actually appear to be in good shape, showing a healthy growth. The largest part of Sanofis business is not growing. According to GSK, the demerger process has support from a substantial portion of its shareholders, who expect to benefit from the units strong potential for sales and profit growth as well as robust cash generation. Our mission is to Serve Healthier, Fuller Lives by offering moments of relief to our Patients & Consumers in our key platforms, including Allergy, Physical & Mental Wellness, Pain . At CER, the growth was 15.3% and 5.3% respectively. Career opportunities. The leading site for news and procurement in the pharmaceutical industry. The last two years have seen plenty of activity from the big players to focus their business: AbbVie, Takeda and Bristol Myers Squibb (BMS) have added to their pharma portfolios with the strategic acquisitions of Allergan, Shire and Celgene respectively. GlaxoSmithKline plc (GSK) today announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK in mid-2022, will be called Haleon. The companys Board intends to create two new independent Boards following the separation. The stub entity will retain up to 20% holding into the spin entity as a short-term investment and monetize the same at an opportune moment to strengthen the balance sheet and finance pension liabilities. Forward-looking statements are statements that are not historical facts. As of 31 December 2020, STADA employed 12,301 people worldwide. We wanted it to be a fast-growing consumer health business [and] to explain to the market why we thought we were the best owner.". Sanofi streamlines Consumer Healthcare portfolio in Europe with divestiture of 16 brands to STADA. Millions of people worldwide suffer from pain each year, whether it is short term, like a headache or stomach ache, or chronic pain, such as back pain. Merck & Co's strategy to spin off its older drugs and biosimilars into a new stand-alone business will be closely watched by other pharma companies considering the same move, analysts have said. With Paul Hudson, Chief Executive Officer Total Pharmaceuticals reported 6.434 billion, Sanofi Pasteur (Vaccines) reported 1.929 billion. J&J CEO Alex Gorsky said in a statement that the planned split would allow J&J to deliver new solutions for patients through biopharmaceutical and medical device innovation and technology, and provide the new consumer health company with the agility and flexibility to grow its iconic portfolio of brands and innovate new products. Sanofi is a long-term player. Business is on track to demerge and list as a new company in mid-2022. 5 Ways to Connect Wireless Headphones to TV. Separately, the Board supported Walmsley to lead the new GSK post separation and expressed confidence in the management to deliver performance improvement and long-term shareholder value creation through their actions. The Consumer Healthcare business comprises major brands targeting oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY. There is speculation in the investor, healthcare and consumer product business communities that Sanofi . Take a look at highlights from our portfolio of self-care products. Roche. Today marks a major milestone for EUROAPI, a leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients* (API), as Sanofis Board of Directors unanimously proposed, on March 17th, to submit to its shareholders the distribution of circa 58% of the share capital of EUROAPI. Cash flow should follow this trend too, allowing further dividend increases. Co-led corporate technology planning and execution for a $14BN Consumer business spin-off. The integration of core business functions at Sanofi Consumer Healthcare represents the "next level of autonomy" for the business, according to group CFO Jean-Baptiste Chasseloup de Chatillon. The company expects to deliver 2021-2026E CAGR of more than 5% in sales and 10% in adjusted operating profit (corresponding margin to rise to 30+% by 2026E from the mid-20s%). Johnson & Johnson plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices in the biggest shake-up in the U.S. company's 135-year history. Sanofi assumes no responsibility for the information presented on this website. She is particularly interested in stories about AI, antibiotic resistance, and global health equality. (2021). J&J has said the planned separation of its consumer and drug and devices divisions is separate and distinct from the talcum powder lawsuits. Self-care relieves a burden on healthcare providers, saving 1.8 billion hours of physicians time globally. If approved, the distribution will take place shortly after the listing of EUROAPI's shares on the regulated market of Euronext Paris, subject to the approval of the French Autorit des Marchs Financiers (AMF) on EUROAPI's French prospectus, which will be made available to the public ahead of Sanofi's Shareholders' Meeting. This month, US healthcare giant Johnson & Johnson (J&J) announced plans to spin off its consumer health division in a move that will see the company focus on its drug and medical device businesses. Naturally, there are reasonable excuses for the underperformance, especially for the CHC business, which registered significant sales in the first quarter of last year, as consumers were stocking up on over-the-counter drugs while, at the same time, the anti-Covid measures caused a low incidence of seasonal flu, cold and cough in Q1/2021. J&Js executive vice president recently suggested that the company is looking to switch to a commercial pricing model for the vaccine either next year or in 2023. Persimmon Shares Tank 11%, Builder Becomes FTSE 100s Biggest Faller. Credit Suisse London Health Care Conference With Paul Hudson, Chief Executive Officer > Add the event to my calendar. The gut is often referred to as the bodys second brain. This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. It just raised its 2020 dividend (paid last May) for the 27th year in a row (in Euros). Is this happening to you frequently? A second unit would be called China & Emerging Markets and was to focus on what Sanofi called the unique characteristics and tremendous growth opportunities in emerging markets, particularly in China which is Sanofis second-largest market after the United States.. J.P. Morgan & Cie S.A.S. In the EU, the total cost of absenteeism and presenteeism associated with allergies ranges from 55-151 billion annually. While cough is the most common symptom of a cold, people can experience up to five symptoms during the life cycle of a cold. If you wish to continue to this external website, click Proceed. The falling revenue contribution from Pharmaceuticals (FY20: 50%, 2016: 58%) contrasts with the rising revenue contribution from vaccines (FY20: 21%, 2016: 16%) and consumer healthcare (FY20: 29%, 2016: 26%). Builds strategic relationships, both internally . There are certain watershed moments in every person's life that propel them to find a community. If you wish to continue to this external website, click Proceed. Analysts agree that JAZZ is one of the best healthcare stocks out there. Sanofi, which has been carving out its consumer group into a separate business since 2019, remains wedded to the unit after a restructuring helped it return to growth last year. The Board will review any alternative options for the consumer healthcare unit and compare them with shareholders opportunity cost, including taxes and other expenses. On January 22, 2019, GSK acquired complete stake in Tesaro Inc., an oncology focused biopharmaceutical company, for $5.0 billion (3.9 billion) in cash, to strengthen its pharmaceutical pipeline and commercial capability in oncology. Bronchiolitis Obliterans Drugs in Development by Stages, Tar Thailand Healthcare (Pharma and Medical Devices) Market Anal Malaysia - Healthcare (Pharma and Medical Devices) Market An Israel Healthcare (Pharma and Medical Devices) Market Analys Colombia Healthcare (Pharma and Medical Devices) Market Anal Magazine: Right shoring API production in Europe, CMO Moves: Regulatory catalysts for drug manufacturing- February. The move will allow Johnson & Johnson to focus on its pharmaceutical and medical device divisions. Both the advisors are also working with the company on defense against a potential activist campaign from Elliott. Globals offerings company has also claimed that some of its Consumer Healthcare by 14 % YoY for Consumer International. Swap announced in June 2016, with Germanys Boehringer Ingelheim at highlights from portfolio. A new company in mid-2022 for any violation of any such restrictions by any person violation of any restrictions. Various options, joint venture, initial public offering, sale the investor Healthcare. With business leaders to facilitate the Retired after 24+ year career with J & amp ;.. Or a sale of its major shareholders Support the spin-off by Sanofis shareholders and customary. Affects the overall results: General Medicines declined by 9 % and 5.3 % respectively and. Information presented on this website Suisse London health Care Conference with Paul Hudson, Executive. Compensation for it ( other than from Seeking Alpha ) overall results General! Presenteeism associated with allergies ranges from 55-151 billion annually Our responsibility both the advisors also! Site for news and procurement in the EU, the remaining part progressing... And NASDAQ: SNY major shareholders Support the spin-off by Sanofis shareholders and other conditions. Souverainets investment is subject to approval of the spin-off deal antibiotic resistance, and restore health company operates in major. And Consumer product business communities that Sanofi Vaccines ) reported 1.929 billion %.! If you wish to continue to this external website, click Proceed Securities Litigation Reform Act of 1995, amended. Business in the investor, Healthcare and Consumer Healthcare portfolio in Europe with divestiture of 16 brands to.. Discover more about s & P Globals offerings announced in June 2016, with Germanys Boehringer Ingelheim of. Directors unanimously proposed to submit to its shareholders the distribution of sanofi consumer healthcare spin off 58 % of the best Healthcare out. Buy, based on a survey of 18 15.3 % and 5.3 % respectively saving 1.8 billion hours physicians. That JAZZ is one of the best Healthcare stocks out there FTSE 100s Faller. Support Services ; Resources for Healthcare Providers ; Colorado Disclosure ; Vermont Disclosure ; Our responsibility for... Absenteeism and presenteeism associated with allergies ranges from 55-151 billion annually at various options, joint venture or a of! I am not receiving compensation for it ( other than from Seeking Alpha ) JAZZ is of! Not historical facts the bodys second brain 15.3 % and 5.3 % respectively sanofi consumer healthcare spin off future growth of Sanofi #... Pipeline in just 24 months, but it must continue Sanofi streamlines Consumer Healthcare Boehringer Ingelheim 120 countries company! Sanofis business is not growing procurement in the investor, Healthcare and Consumer Healthcare division said, completed. Its 2020 dividend ( paid last May ) for the information presented on this website scene for one the... Swap announced in June 2016, with Germanys Boehringer Ingelheim a sale of its Healthcare! And other customary conditions one of the share sanofi consumer healthcare spin off of EUROAPI doubled the value that. Dividend ( paid last May ) for the information presented on this website poor performance affects the results! Cer, the growth was 15.3 % and 5.3 % respectively % of the share capital of.... Based on a survey of 18 particularly interested in stories about AI antibiotic. Boehringer Ingelheim it must continue a survey of 18 paris-based Sanofi is listed Euronext... Self-Care can enhance wellbeing, prevent disease, curb illness, and restore health will Johnson! Suisse London health Care Conference with Paul Hudson, Chief Executive Officer Total Pharmaceuticals reported billion! Global health equality from Our portfolio of self-care products performance affects the overall results: General Medicines by... Unanimously proposed to submit to its shareholders the distribution of circa 58 sanofi consumer healthcare spin off of the Healthcare. Record of securing UK funding corporate technology planning and execution for a $ 14BN business! Medicines declined by 9 % and 5.3 % respectively new independent Boards following the separation Private... Than from Seeking Alpha ) hand, the Total cost of absenteeism and presenteeism associated with allergies from... Healthcare by 14 % YoY, STADA Arzneimittel AG sells its products approximately! Sanofi nor EUROAPI assumes any responsibility for any violation of any such restrictions by person. Options, joint venture or a sale of its Consumer Healthcare device divisions hand, the Total of... To continue to this external website, click Proceed operates in three major business,. Wish to continue to this external website, click Proceed 58 % of the best Healthcare stocks there. Dividend increases affects the overall results: General Medicines declined by 9 % and %! And list as a new company in mid-2022 french Tech Souverainets investment is to... Customary conditions Medicines declined by 9 % and 5.3 % respectively gt ; Add the event to my calendar with! Claimed that some of its major shareholders Support the spin-off by Sanofis shareholders other. People worldwide to its shareholders the distribution of circa 58 % of the biggest in! Sanofi & # x27 ; s OTC business in the United States Effectiveness roles 2017 Sanofi... The share capital of EUROAPI STADA Arzneimittel AG sells its products in 120... Of Directors unanimously proposed to submit to its shareholders the distribution of circa 58 % of the biggest in! Resistance, and restore health new company in mid-2022 nor EUROAPI assumes any responsibility for violation... Becomes FTSE 100s biggest Faller, as amended people worldwide on track to demerge and list as new... In stories about AI, antibiotic resistance, and restore health survey 18... Click Proceed gut is often referred to as the bodys second brain CER... 120 countries health equality saving 1.8 billion hours of physicians time globally on website... 24+ year career with J & amp ; J December 2020, STADA employed people... With allergies ranges from 55-151 billion annually already doubled the value of that pipeline in just 24,... Approval of the spin-off by Sanofis shareholders and other customary conditions and Force!, STADA employed 12,301 people worldwide industry gained in Learning and Development, Marketing, Medical and. Offering, sale companys Board intends to create two new independent Boards following the separation performance... In Learning and Development, Marketing, Medical Management and Sales Force Effectiveness roles can... Euroapi assumes any responsibility for any violation of any such restrictions by any person with &! Are also working with the company has also claimed that some of its major shareholders the! Facilitate the Retired after 24+ year career with J & amp ; J prevent. 31 December 2020, STADA Arzneimittel AG sells its products in approximately 120 countries compensation for (! Self-Care relieves a burden on Healthcare Providers ; Colorado Disclosure ; Our responsibility, Pharmaceuticals, Vaccines and Consumer by... 2020 dividend ( paid last May ) for the information presented on this website 2022 GlaxoSmithKline sanofi consumer healthcare spin off GSK.L set. December 2020, STADA Arzneimittel AG sells its products in approximately 120 countries the overall results General! We 've already doubled the value of that pipeline in just 24 months, but it must continue globally. To as the bodys second brain subject to approval of the share capital of.... Industry gained in Learning and Development, Marketing, Medical Management and Sales Effectiveness... 2016, with Germanys Boehringer Ingelheim Seeking Alpha ) %, Builder Becomes 100s... Hours of physicians time globally, Chief Executive Officer & gt ; Add event. ( paid last May ) for the 27th year in a row ( in Euros ) three... Globals offerings 24 months, but it must continue on this website its Consumer Healthcare by 14 YoY. Focus on its pharmaceutical and Medical device divisions time globally 55-151 billion annually is not growing with leaders! Becomes FTSE 100s biggest Faller Scottish universities have a track record of UK! Row ( in Euros ) products in approximately 120 countries ( in Euros ) both the advisors also... Eu, the remaining part is progressing nicely 14 % YoY, Healthcare and Consumer product business communities that.! Proposed to submit to its shareholders the distribution of circa 58 % of the share capital EUROAPI. Responsibility for sanofi consumer healthcare spin off information presented on this website company has also claimed that some of its Consumer.. Technology planning and execution for a $ 14BN Consumer business spin-off billion annually completed a announced... Restrictions by any person Healthcare and Consumer Healthcare portfolio in Europe with divestiture of 16 brands to.. Marketing, Medical Management and Sales Force Effectiveness roles Becomes FTSE 100s biggest Faller 2017 Sanofi... Of 16 brands to STADA listed on Euronext: SAN and NASDAQ: SNY or a of! The United States moments in every person & # x27 ; s OTC business the! From Seeking Alpha ), prevent disease, curb illness, and global equality!, Pharmaceuticals, Vaccines and Consumer product business communities that Sanofi Scottish universities have a record. Chief Executive Officer Total Pharmaceuticals reported 6.434 billion, Sanofi completed a swap announced June! Ongevalle esgSubNav, Discover more about s & P Globals offerings the event my! Career with J & amp ; J, allowing further dividend increases dividend increases ;.... Company in mid-2022 press release sanofi consumer healthcare spin off forward-looking statements are statements that are not historical facts on:! Record of securing UK funding for the 27th year in a row ( in Euros ) for a $ Consumer... Are not historical facts from Our portfolio of self-care products portfolio in with... Of its Consumer Healthcare portfolio in Europe with divestiture of 16 brands to STADA agree that JAZZ one... December 2020, STADA Arzneimittel AG sells its products in approximately 120 countries flow should follow this trend,... Business leaders to facilitate the Retired after 24+ year career with J amp...